WIERENGA WENDELL bought CYTK
April 15, 2026 · Form 4 insider transaction
WIERENGA WENDELL bought 95 shares of Cytokinetics, Incorporated at $65.37 per share, a transaction worth $6.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
95
Price
$65.37
Total value
$6.2K
InsiderWIERENGA WENDELL
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 15, 2026
Filing dateApril 15, 2026
Shares owned after32,637
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of common stock granted pursuant to Director Equity in Lieu of Cash Retainer Program. Shares are fully vested.